Info: Read More
  • 中药标准品生产商,产品定制服务
  • 京尼平甙; 栀子甙

    Geniposide

    京尼平甙; 栀子甙
    产品编号 CFN98261
    CAS编号 24512-63-8
    分子式 = 分子量 C17H24O10 = 388.4
    产品纯度 >=98%
    物理属性 Powder
    化合物类型 Iridoids
    植物来源 The fruits of Gardenia jasminoides Ellis.
    ChemFaces的产品在影响因子大于5的优秀和顶级科学期刊中被引用
    提供自定义包装
    产品名称 产品编号 CAS编号 包装 QQ客服
    京尼平甙; 栀子甙 CFN98261 24512-63-8 10mg QQ客服:1457312923
    京尼平甙; 栀子甙 CFN98261 24512-63-8 20mg QQ客服:1457312923
    京尼平甙; 栀子甙 CFN98261 24512-63-8 50mg QQ客服:1457312923
    京尼平甙; 栀子甙 CFN98261 24512-63-8 100mg QQ客服:1457312923
    存储与注意事项
    1. 在您收到产品后请检查产品。如无问题,请将产品存入冰霜并且样品瓶保持密封,产品可以存放长达24个月(2-8摄氏度)。

    2. 只要有可能,产品溶解后,您应该在同一天应用于您的实验。 但是,如果您需要提前做预实验,或者需要全部溶解,我们建议您将溶液以等分试样的形式存放在-20℃的密封小瓶中。 通常,这些可用于长达两周。 使用前,打开样品瓶前,我们建议您将产品平衡至室温至少1小时。

    3. 需要更多关于溶解度,使用和处理的建议? 请发送电子邮件至:service@chemfaces.com
    订购流程
  • 1. 在线订购
  • 请联系我们QQ客服

  • 2. 电话订购
  • 请拨打电话:
    027-84237683 或 027-84237783

  • 3. 邮件或传真订购
  • 发送电子邮件到: manager@chemfaces.com 或
    发送传真到:027-84254680

  • 提供订购信息
  • 为了方便客户的订购,请需要订购ChemFaces产品的客户,在下单的时候请提供下列信息,以供我们快速为您建立发货信息。
  •  
  • 1. 产品编号(CAS No.或产品名称)
  • 2. 发货地址
  • 3. 联系方法 (联系人,电话)
  • 4. 开票抬头 (如果需要发票的客户)
  • 5. 发票地址(发货地址与发票地址不同)
  • 发货时间
    1. 付款方式为100%预付款客户,我们将在确认收到货款后当天或1-3个工作日发货。

    2. 付款方式为月结的客户,我们承诺在收到订单后当天或1-3个工作日内发货。

    3. 如果客户所需要的产品,需要重新生产,我们有权告知客户,交货时间需要延期。
    ChemFaces的产品在许多优秀和顶级科学期刊中被引用

    Cell. 2018 Jan 11;172(1-2):249-261.e12.
    doi: 10.1016/j.cell.2017.12.019.
    IF=36.216(2019)

    PMID: 29328914

    Cell Metab. 2020 Mar 3;31(3):534-548.e5.
    doi: 10.1016/j.cmet.2020.01.002.
    IF=22.415(2019)

    PMID: 32004475

    Mol Cell. 2017 Nov 16;68(4):673-685.e6.
    doi: 10.1016/j.molcel.2017.10.022.
    IF=14.548(2019)

    PMID: 29149595

    ACS Nano. 2018 Apr 24;12(4): 3385-3396.
    doi: 10.1021/acsnano.7b08969.
    IF=13.903(2019)

    PMID: 29553709

    Nature Plants. 2016 Dec 22;3: 16206.
    doi: 10.1038/nplants.2016.205.
    IF=13.297(2019)

    PMID: 28005066

    Sci Adv. 2018 Oct 24;4(10): eaat6994.
    doi: 10.1126/sciadv.aat6994.
    IF=12.804(2019)

    PMID: 30417089
    我们的产品现已经出口到下面的研究机构与大学,并且还在增涨
  • China Medical University (Taiwan)
  • University of Melbourne (Australia)
  • University of Hull (United Kingdom)
  • John Innes Centre (United Kingdom)
  • Rio de Janeiro State University (Brazil)
  • Pennsylvania State University (USA)
  • Universidade de Franca (Brazil)
  • Harvard University (USA)
  • Tohoku University (Japan)
  • Uniwersytet Gdański (Poland)
  • St. Jude Children Research Hospital (USA)
  • Universidad Miguel Hernández (Spain)
  • Siksha O Anusandhan University (India)
  • Kyoto University (Japan)
  • More...
  • 国外学术期刊发表的引用ChemFaces产品的部分文献
  • Molecules.2020, 25(23):5609.
  • Evid Based Complement Alternat Med.2021, 2021:8850744.
  • Molecules2020, 25(4):892
  • Journal of Oil Palm Research2019, 31(2):238-247
  • Front Pharmacol.2022, 13:919230.
  • Curr Res Virol Sci.2022, 3:100019.
  • Biochemistry.2018, 57(40):5886-5896
  • Biomedicines.2020, 8(11):486.
  • Chem Biol Interact.2020, 328:109200.
  • Preprints2022, 2022030063.
  • Life Sci.2021, 270:119074.
  • Antioxidants.2022, 11(4), 67.
  • J Chromatogr A.2022, 1685:463640.
  • Korean J. Crop Sci.2018, 63(2):131-139
  • Biomed Pharmacother.2022, 145:112410.
  • Phytomedicine.2019, 61:152813
  • Malaysian Journal of Analytical Sciences2022, 26(2):360-369.
  • Front Pharmacol.2022, 13:972825.
  • Cell.2018, 172(1-2):249-261
  • Asian J Beauty Cosmetol2020, 18(3): 265-272.
  • International Food Research Journal2018, 25(6):2560-2571
  • Heliyon.2022, 8(12):e12031.
  • Antibiotics.2022, 11(4), 510.
  • ...
  • 生物活性
    Description: Geniposide exhibits anti-diabetic, antidepressant-like, antioxidative, anti-apoptotic, antiproliferative and neuroprotective activities. Geniposide is an agonist for GLP-1 receptor, it regulates expression of anti-oxidative proteins including HO-1 and Bcl-2 by activating the transcriptor of p90RSK via MAPK signaling pathway in PC12 cells. Geniposide may suppress TGF-β1-induced EMT in hepatic fibrosis by inhibiting the TGFβ/Smad and ERK-mitogen-activated protein kinase (MAPK) signaling pathways.
    Targets: TLR | p53 | Bcl-2/Bax | Caspase | TGF-β/Smad | ERK | p38MAPK | HO-1 | MEK | Raf | Beta Amyloid | BACE | TNF-α | IL Receptor | JNK | ROS | NF-kB | IkB | IKK
    In vitro:
    Neurochem Int. 2007 Nov-Dec;51(6-7):361-9.
    Geniposide, a novel agonist for GLP-1 receptor, prevents PC12 cells from oxidative damage via MAP kinase pathway.[Pubmed: 17629357]
    Alzheimer's disease (AD) is the most common form of dementia. Glucagon-like peptide-1 (GLP-1) gives a new genre in therapeutic targets for intervention in AD with its neurotrophic and neuroprotective functions. In previous work, we identified that geniposide is a novel agonist for GLP-1 receptor, which shows neurotrophic characteristics to induce the neuronal differentiation of PC12 cells.
    METHODS AND RESULTS:
    The aim of this study is to determine whether geniposide prevents neurons from oxidative damage, and to explore its signaling pathways. The results demonstrated that geniposide increased the expression of anti-apoptotic proteins, including Bcl-2 and heme oxygenase-1 (HO-1), to antagonize the oxidative damage in PC12 cells induced by hydrogen peroxide. LY294002 (a PI3K inhibitor) inhibited the effect of geniposide increasing of Bcl-2 level by activation of MAPK, MEK and c-Raf phosphorylation in hydrogen peroxide treated PC12 cells. U0126 (a selective inhibitor of MEK) also attenuated the enhancement of geniposide on Bcl-2 level by inhibiting the phosphorylation of p90RSK in the hydrogen peroxide treated PC12 cells.
    CONCLUSIONS:
    All these data demonstrate that geniposide, an agonist for GLP-1 receptor, regulates expression of anti-oxidative proteins including HO-1 and Bcl-2 by activating the transcriptor of p90RSK via MAPK signaling pathway in PC12 cells.
    Int Immunopharmacol. 2012 Dec;14(4):792-8.
    Geniposide, from Gardenia jasminoides Ellis, inhibits the inflammatory response in the primary mouse macrophages and mouse models.[Pubmed: 22878137 ]
    Geniposide, a main iridoid glucoside component of gardenia fruit, has been known to exhibit antibacterial, anti-inflammatory and other important therapeutic activities. The objective of this study was to investigate the protective effects of geniposide on inflammation in lipopolysaccharide (LPS) stimulated primary mouse macrophages in vitro and LPS induced lung injury model in vivo.
    METHODS AND RESULTS:
    The expression of pro-inflammatory cytokines was determined by enzyme-linked immunosorbent assay (ELISA). Nuclear factor-kappa B (NF-κB), inhibitory kappa B (IκBα) protein, p38, extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK) and Toll-like receptor 4 (TLR4) were determined by Western blot. Further analysis was carried out in mTLR4 and mMD-2 co-transfected HEK293 cells. The results showed that geniposide markedly inhibited the LPS-induced TNF-α, IL-6 and IL-1β production both in vitro and in vivo. Geniposide blocked the phosphorylation of IκBα, p65, p38, ERK and JNK in LPS stimulated primary mouse macrophages. Furthermore, geniposide inhibited the expression of TLR4 in LPS stimulated primary mouse macrophages and inhibited the LPS-induced IL-8 production in HEK293-mTLR4/MD-2 cells. In vivo study, it was also observed that geniposide attenuated lung histopathologic changes in the mouse models.
    CONCLUSIONS:
    These results suggest that geniposide exerts an anti-inflammatory property by down-regulating the expression of TLR4 up-regulated by LPS. Geniposide is highly effective in inhibiting acute lung injury and may be a promising potential therapeutic reagent for acute lung injury treatment.
    Ethnopharmacol . 2016 Jun 5;185:77-86.
    Geniposide attenuates inflammatory response by suppressing P2Y14 receptor and downstream ERK1/2 signaling pathway in oxygen and glucose deprivation-induced brain microvascular endothelial cells[Pubmed: 26976766]
    Ethnopharmacological relevance: Fructus gardenia is widely used for treatment of stroke and infectious diseases in Chinese medicine. Geniposide is the key bioactive compound related to the pharmacodynamic actions of gardenia on ischemic stroke. The molecular mechanism by which geniposide improves the ischemic brain injury was observed in the study. Aim of the study: Recent studies showed that geniposide had protective activities against the inflammatory response in ischemic stroke. However, the molecular mechanism of geniposide anti-inflammatory role has not yet been fully elucidated. In this study, we investigated the effect of geniposide on the expression of P2Y14 receptor and downstream signaling pathway in brain microvascular endothelial cells (BMECs). Materials and methods: An in vitro model of cerebral ischemia in BMECs was established by oxygen-glucose-deprivation (OGD). To further confirm the specific effect of geniposide on P2Y14 receptor and downstream signaling pathways, we set up a UDP-glucose (an agonist of the P2Y14 receptor) stimulated model. After administration of geniposide, the expression of P2Y14 receptor, phosphorylation of RAF-1, mitogen activated protein kinase kinase1/2 (MEK1/2), extracellular signal-regulated kinase 1/2 (ERK1/2), level of interleukin-8 (IL-8), interleukin-1β (IL-1β), monocyte chemotactic protein 1 (MCP-1) in BMECs were determined. Results: The mRNA and protein expression of P2Y14 in the rat BMECs were up-regulated in OGD-induced injury. After administration of Geniposide, the expression of P2Y14 receptor was significantly down-regulated, the phosphorylation of RAF-1, MEK1/2, ERK1/2 were suppressed. Similar data were obtained in UDP-glc stimulated model. We also observed that geniposide markedly declined the production of IL-8, IL-1β and MCP-1 in OGD-induced BMECs. Conclusion: Geniposide exerted anti-inflammatory effects by interfering with the expression of P2Y14 receptor, which subsequently inhibits the downstream ERK1/2 signaling pathways and the release of the pro-inflammatory cytokines IL-8, MCP-1, IL-1β. Therefore, this study provides the evidence for gardenia's clinical application in cerebral ischemia. Keywords: Anti-inflammation; Brain microvascular endothelial cells; ERK1/2 signaling pathway; Geniposide; Geniposide (PubChem CID: 107848); P2Y(14) receptor. Copyright © 2016 Elsevier Ireland Ltd. All rights reserved.
    In vivo:
    Eur Neuropsychopharmacol. 2015 Apr 17.
    Antidepressant-like effect of geniposide on chronic unpredictable mild stress-induced depressive rats by regulating the hypothalamus-pituitary-adrenal axis.[Pubmed: 25914157]
    Geniposide as the major active component of Gardenia jasminoides Ellis has neuroprotective activity.
    METHODS AND RESULTS:
    This study elucidated the potential antidepressant-like effect of Geniposide and its related mechanisms using a depression rat model induced by 3 consecutive weeks of chronic unpredictable mild stress (CUMS). Sucrose preference test, open field test (OFT) and forced swimming test (FST) were applied to evaluate the antidepressant effect of Geniposide. We found that Geniposide (25, 50, 100mg/kg) treatment reversed the CUMS-induced behavioral abnormalities, as suggested by increased sucrose intake, improved crossing and rearing behavior in OFT, shortened immobility and prolonged swimming time in FST. Additionally, Geniposide treatment normalized the CUMS-induced hyperactivity of HPA axis, as evidenced by reduced CORT serum level, adrenal gland index and hypothalamic CRH mRNA expression, with no significant effect on ACTH serum level. Moreover, Geniposide treatment upregulated the hypothalamic GRα mRNA level and GRα protein expression in PVN, suggesting Geniposide could recover the impaired GRα negative feedback on CRH expression and HPA axis.
    CONCLUSIONS:
    These aforementioned therapeutic effects of Geniposide were essentially similar to fluoxetine.
    Our results indicated that Geniposide possessed potent antidepressant-like properties that may be mediated by its effects on the HPA axis.
    制备储备液(仅供参考)
    1 mg 5 mg 10 mg 20 mg 25 mg
    1 mM 2.5747 mL 12.8733 mL 25.7467 mL 51.4933 mL 64.3666 mL
    5 mM 0.5149 mL 2.5747 mL 5.1493 mL 10.2987 mL 12.8733 mL
    10 mM 0.2575 mL 1.2873 mL 2.5747 mL 5.1493 mL 6.4367 mL
    50 mM 0.0515 mL 0.2575 mL 0.5149 mL 1.0299 mL 1.2873 mL
    100 mM 0.0257 mL 0.1287 mL 0.2575 mL 0.5149 mL 0.6437 mL
    * Note: If you are in the process of experiment, it's need to make the dilution ratios of the samples. The dilution data of the sheet for your reference. Normally, it's can get a better solubility within lower of Concentrations.
    部分图片展示
    产品名称 产品编号 CAS编号 分子式 = 分子量 位单 联系QQ
    京尼平; Genipin CFN99142 6902-77-8 C11H14O5 = 226.23 20mg QQ客服:3257982914
    京尼平甙; 栀子甙; Geniposide CFN98261 24512-63-8 C17H24O10 = 388.4 20mg QQ客服:2056216494
    京尼平-1-O-龙胆双糖苷; Genipin-1-O-gentiobioside CFN98524 29307-60-6 C23H34O15 = 550.51 20mg QQ客服:1413575084
    黄夹苦苷; Theviridoside CFN98241 23407-76-3 C17H24O11 = 404.4 5mg QQ客服:2056216494
    鸡矢藤次苷甲酯; Feretoside CFN98330 27530-67-2 C17H24O11 = 404.4 10mg QQ客服:2159513211
    去乙酰车叶草苷酸甲酯; Deacetylasperulosidic acid methyl ester CFN92359 52613-28-2 C17H24O11 = 404.4 20mg QQ客服:3257982914
    6-乙氧基京尼平苷; 6-Ethoxygeniposide CFN96738 1264496-61-8 C19H28O11 = 432.42 5mg QQ客服:1413575084
    交让木苷; Daphylloside CFN99468 14260-99-2 C19H26O12 = 446.4 10mg QQ客服:3257982914
    鸡屎藤苷甲酯; Paederosidic acid methyl ester CFN92525 122413-01-8 C19H26O12S = 478.5 20mg QQ客服:1413575084
    10-O-咖啡酰基-脱乙酰基交让木苷; 10-O-Caffeoyl-6-epiferetoside CFN97953 83348-22-5 C26H30O14 = 566.5 5mg QQ客服:215959384

    信息支持


    公司简介
    订购流程
    付款方式
    退换货政策

    ChemFaces提供的产品仅用于科学研究使用,不用于诊断或治疗程序。

    联系方式


    电机:027-84237783
    传真:027-84254680
    在线QQ: 1413575084
    E-Mail:manager@chemfaces.com

    湖北省武汉沌口经济技术开区车城南路83号1号楼第三层厂房


    ChemFaces为科学家,科研人员与企业提供快速的产品递送。我们通过瑞士SGS ISO 9001:2008质量体系认证天然化合物与对照品的研发和生产